Melissa Layman, Chief Commercial Officer at Flexion Therapeutics Inc (FLXN), sold 2,624 shares at $12.55 ($33K) on 2021-01-28, disclosed to the SEC on 2021-01-29.
Open-market sale of $33k FLXN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.